Long-term blood-thinner therapy registry for heart disease
Part of Heart & circulation, Pain clinical trials.
This study follows people with known coronary artery disease to understand how long-term “blood thinner” treatments are used and how they affect health over time. You may be asked to share medical information and come in for follow-up to help researchers compare outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have confirmed coronary artery disease (for example, prior heart attack or a heart procedure, or evidence on a scan).
- You can and are willing to sign informed consent to take part.
- Your last “acute coronary syndrome” event (a recent heart circulation emergency) was more than 12 months ago.
- You have not had a stroke in the last 6 months.
- You do not have very severe end-stage heart failure (NYHA class IV).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial follows people with atrial fibrillation to see how long-term blood-thinning treatment affects outcomes over time. It may help determine which long-term approach best lowers stroke and clot risks for patients like you.
This study looks at real-world outcomes for people with narrowed heart arteries (coronary artery disease). It may include those treated with stents (PCI) or medicines. Doctors will use a special computer tool to measure the severity of blockages and track health over time.
This study looks at how blood-thinning medications (like aspirin and clopidogrel) work in people with hardened arteries or peripheral artery disease (PAD). By understanding this, doctors hope to improve treatment and prevent heart attacks and strokes.
This trial is checking whether current tools can accurately predict bleeding and clotting risks in people with coronary heart disease who are on long-term blood thinners. It aims to help doctors make safer treatment decisions.
This study follows people who receive a stent to open a blocked heart artery and checks how well their blood-thinning medicine works using a simple blood test. The goal is to learn more about the best ways to prevent blood clots in similar patients.
This registry collects information from people with coronary (heart) artery disease who already had platelet-related blood tests as part of usual care. The goal is to better understand how platelet responses relate to treatment and outcomes, which may help future care.
Hear when a new Peripheral Artery Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.